FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Slate Run Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Bupropion hydrochloride XL from Slate Run Pharmaceuticals, approving the extended-release formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Nicotine Dependence
• Seasonal Affective Disorder

Drugs mentioned

• BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)